DHG, a new depolymerized holothurian glycosaminoglycan, exerts an antithrombotic effect with less bleeding than unfractionated or low molecular weight heparin, in rats

Thrombosis Research

Volumn 84, Issue 2, 1996, Pages 111-120

  Kitazato, Kenji ^a   Kitazato, Keiko T ^a   Nagase, Hideki ^a   Minamiguchi, Kazuhisa ^a  

^a TAIHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

glycosaminoglycan; haemorrhage; rat; venous thrombus formation

Indexed keywords

DERMATAN SULFATE; GLYCOSAMINOGLYCAN; HEPARIN; HOLOTHURIAN GLYCOSAMINOGLYCAN; LOW MOLECULAR WEIGHT HEPARIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLEEDING; CONTROLLED STUDY; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; THROMBOGENESIS; THROMBOSIS PREVENTION;

EID: 0030588206     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/0049-3848(96)00166-1     Document Type: Article

References (26)

1. MANT MJ, O'BRIEN BD, THONG KL, HAMMOND GW, BIRTWHISTLE RV, GRACE GC Haemorrhagic complications of heparin therapy. Lancet. 1:1977;1133-1135.
2. SALZMAN EW, DEYKIN D, SHAPIRO RM, ROSENBERG RD Management of heparin therapy - Controlled prospective trial. N Engl J Med. 292:1975;1046-1050.
3. HIRSH J, LEVINE MN Low molecular weight heparin. Blood. 79:1992;1-17.
4. FAN HZ, CHEN JD, LIN KZ Isolation of an acidic mucopolysaccharide from Stichopus japonicus Selenka and some of its physical and chemical properties. Tao Hsueh Hsueh Pao. 15:1980;263-270.
5. LI JZ, BAO CG, CHEN GZ, ZHANG GZ, ZHANG ZF, FAN HZ, CHEN J, HAO X Preliminary study on the effect of acid mucopolysaccharide from Stichopus japonicus Selenka on hemostasis. Zhogyao Tongbao. 8:1983;36-39.
6. TAKAMATSU J, SAITO H, KAMIYA T, MURANAKA Y, MINAMI Y, FAN HZ A new mucopolysaccharide from Stichopus japonicus (sea cucumber) and its anticogulant properties. Thromb Haemost. 58:1987;379. (Abstr).
7. LI JZ, LIAN ECY Aggregation of human platelets by acidic mucopolysaccharide extracted from Stichopus japonicus Selenka. Thromb Haemost. 59:1988;435-439.
8. SUZUKI N, KITAZATO K, TAKAMATSU J, SAITO H Antithrombotic and anticoagulant activity of depolymerized fragment of the glycosaminoglycan extracted from Stichopus japonicus Selenka. Thromb Haemost. 65:1991;369-373.
9. YOSHIDA K, MINAMI Y, NEMOTO H, NUMATA K, YAMANAKA E Structure of DHG, a depolymerized glycosaminoglycan from sea cucumber, Stichopus japonicus. Tetrahedron Lett. 33:1992;4959-4962.
10. NAGASE H, ENJYOJI K, MINAMIGUCHI K, KITAZATO KT, KITAZATO K, SAITO H, KATO H Depolymerized holothurian glycosaminoglycan with novel anticoagulant actions: antithrombin III- and heparin cofactor II-independent inhibition of factor X activation by factor IXa-factor VIIIa complex and heparin cofactor II-dependent inhibition of thrombin. Blood. 85:1995;1527-1534.
11. NAGASE H, ENJYOJI K, SHIMA M, KITAZATO K, YOSHIOKA A, SAITO H, KATO H Effect of depolymerized holothurian glycosaminoglycan (DHG) on the activation of factor VIII and factor V by thrombin. J Biochem. 119:1996;63-69.
12. TRAN TH, LAMMLE B, ZBINDEN B, DUCKERT F Heparin cofactor II: Purification and antibody production. Thromb Haemost. 55:1986;19-23.
13. DEJANA E, VILLA S, DE GAETANO G Bleeding time in rats: a comparison of different experimental conditions. Thromb Haemost. 48:1982;108-111.
14. ANDRIUOLI R, MASTACCHI R, BARBANTI M, SARRET M Comparison of the antithrombotic and haemorrhagic effects of heparin and a new low molecular weight heparin in rats. Haemostasis. 15:1985;324-330.
15. WESSLER S, REIMER SM, SHEPS MC Biologic assays of a thrombosis-inducing activity in human serum. J Appl Physiol. 14:1959;943-946.
16. OFOSU FA, FERNANDEZ F, ANVARI N, CARANOBE C, DOL F, CADROY Y, PETITOU M, MARDIGUIAN J, SIE P, BONEU B Further studies on the mechanisms for the antithrombotic effects of sulfated polysaccharides in rabbits. Thromb Haemost. 60:1988;188-192.
17. DOL F, PETITOU M, LORMEAU JC, CHOAY J, CARANOBE C, SIE P, SAIVIN S, HOUIN G, BONEU B Pharmacologic properties of the low molecular weight dermatan sulfate: comparison with unfractionated dermatan sulfate. J Lab Clin Med. 115:1990;43-51.
18. BARBANTI M, CALANNI F, MILANI MR, MARCHI E, SEMERARO N, COLUCCI M Therapeutic effect of a low molecular weight dermatan sulphate (Desmin 370) in rat venous thrombosis-evidence for an anticoagulant-independent mechanism. Thromb Haemost. 69:1993;147-151.
19. GRAY E, CESMELI S, LORMEAU JC, DAVIES AB, LANE DA Low affinity heparin is an antithrombotic agent. Thromb Haemost. 71:1994;203-207.
20. BARROW RT, PARKER ET, KRISHNASWAMY S, LOLLER P Inhibition by heparin of the human blood coagulation intrinsic pathway factor X activator. J Biol Chem. 269:1994;26796-26800.
21. FERNANDEZ F, VAN RYN J, OFOSU FA, HIRSH J, BUCHANAN MR The haemorrhagic and antithrombotic effects of dermatan sulphate. Br J Haematol. 64:1986;309-317.
22. MAGGI A, ABBADINI M, PAGGELLA PG, BOROWSKA A, PANGRAZZI J, DONATI MB Antithrombotic properties of dermatan sulfate in a rat venous thrombosis model. Haemostasis. 17:1987;329-335.
23. MERTON RE, THOMAS DP Experimental studies on the relative efficacy of dermatan sulfate and heparin as antithrombotic agents. Thromb Haemost. 58:1987;839-842.
24. AGNELLI G, COSMI B, FILIPPO PD, RANUCCI V, VESCHI F, LONGETTI M, RENGA C, BARZI F, GIANESE F, LUPATTELLI L, RINONAPOLI E, NENCI GG A randomized, double-blind, placebo-controlled trial of dermatan sulfate for prevention of deep vein thrombosis in hip fracture. Thromb Haemost. 67:1992;203-208.
25. COHEN AT, PHILLIPS MJ, EDMONDSON RA, SKINNER JA, DAS SK, COOPER DJ, THOMAS EM, MELISSARI E, KAKKAR VV A dose ranging study to evaluate dermatan sulphate in preventing deep vein thrombosis following total hip arthroplasty. Thromb Haemost. 72:1994;793-798.
26. PALM M, MATTSSON C, SVAHN CM, WEBER M Bleeding times in rats treated with heparin, heparin fragments of high and low anticoagulant activity and chemically modified heparin fragments of low anticoagulant activity. Thromb Haemost. 64:1990;127-132.